Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Pharma
AZ, Daiichi's Enhertu cleared by FDA in wide range of tumors
With Enhertu at the heart of AZ and Daiichi's goals for growth, the partners have just significantly expanded the ADC's reach in the U.S.
Fraiser Kansteiner
Apr 8, 2024 10:49am
Daiichi Sankyo spends €1B to bulk up in ADCs
Feb 20, 2024 9:50am
Samsung Biologics, LegoChem link to propel ADC development
Feb 7, 2024 10:16am
Newly spun-off WuXi XDC locks up ADC deal with Korea's Celltrion
Jan 24, 2024 11:04am
Pfizer's $43B buyout of ADC specialist Seagen is a done deal
Dec 14, 2023 10:57am
WuXi XDC to funnel IPO proceeds into manufacturing expansions
Nov 7, 2023 10:53am